Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localized Pancreatic Adenocarcinoma”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Not applicableLooking for participantsNCT07206355
What this trial is testing

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

Who this might be right for
Biliary Tract Cancer (BTC)Biliary Tract Cancer (CCA)Cholangiocarcinoma+4 more
University of Nottingham 160
Testing effectiveness (Phase 2)Ended earlyNCT05289830
What this trial is testing

Escitalopram to Placebo in Patients With Localized Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPeriampullary Cancer
Case Comprehensive Cancer Center 4
Large-scale testing (Phase 3)Study completedNCT00057876
What this trial is testing

Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group 74
Testing effectiveness (Phase 2)Ended earlyNCT02910882
What this trial is testing

PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma Non-resectable
Scripps Health 4
Very early researchEnded earlyNCT01783054
What this trial is testing

Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas

Who this might be right for
Adenocarcinoma Pancreas
Medical University of South Carolina 2
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Not applicableStudy completedNCT00900016
What this trial is testing

Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery

Who this might be right for
Pancreatic Cancer
Fox Chase Cancer Center 37
Testing effectiveness (Phase 2)Ended earlyNCT01677988
What this trial is testing

Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma

Who this might be right for
Adenocarcinoma of Head of Pancreas
Medical University of South Carolina 3
Not applicableStudy completedNCT06699667
What this trial is testing

CT Findings in Surgically Treated Focal Pancreatic Disease- A Retrospective Study

Who this might be right for
Autoimmune Pancreatitis
Rigshospitalet, Denmark 41
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Very early researchStudy completedNCT03572283
What this trial is testing

Bethanechol Prior to Pancreatic Surgery

Who this might be right for
Pancreas Cancer
Columbia University 17
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Not applicableStudy completedNCT00489515
What this trial is testing

Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder

Who this might be right for
Colorectal CancerGallbladder CancerGastric Cancer+2 more
Wake Forest University Health Sciences 115
Testing effectiveness (Phase 2)Temporarily pausedNCT00637364
What this trial is testing

High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain

Who this might be right for
PainPancreatic AdenocarcinomaDuctal Adenocarcinoma
CMED HIFU Development Corporation 5
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Testing effectiveness (Phase 2)UnknownNCT00553683
What this trial is testing

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)UnknownNCT05048524
What this trial is testing

Peri-operative SLOG for Localized Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreas Cancer
National Health Research Institutes, Taiwan 64
Next Page